SO vs SYRE · P/E 22, rev $29.55B vs $7.60B cap
Southern Company (SO) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
SO currently screens at market cap $101.55B and trailing P/E 22.1. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the SO and SYRE stock pages for the full models.
Not investment advice.